Podcasts about harvoni

Bleeding Red Sox red, and making Hep-C sexy. Listen...

In this episode: Medical News (1:50) – Link between nighttime light exposure and depression Preventative Medicine Tip (5:55) – Diabetes Screening Recommendations (https://www.uspreventiveservicestaskforce.org/) Guest Interview (13:50) – Ariana Grossu, Outreach Advisor at the Office for Civil Rights at the US Department of Health & Human Services, discusses the newest HHS initiative – the Conscience and Religious Freedom Division – and what current and potential policies protect health care workers from having to violate their conscience in their practice. For more information visit: www.hhs.gov/conscience Medical Trivia (Answer at 39:15) – According to MedScape.com, which of these prescription medications garnered the most sales in 2016 - at $13.6 billion? 1. Enbrel (etanercept) 2. Harvoni (ledipasvir sofosbuvir) 3. Lantus Solostar (insulin glargine injection) 4. Humira (Adalimunab) 5. Remicade (infliximab) Listener Question (42:30) – If I took birth control when I was younger before I knew about the harmful effects, is there anything I can do now to decrease my risk of getting cancer? Medicine You Need to Know (45:20) – Catholic Witness in Healthcare editor Dr. John Travaline discusses how St. Padre Pio’s vision for authentic Catholic healthcare is coming to the United States ------ Live: www.redeemerradio.com Follow us on Facebook: @DoctorDoctorShow Submit your question(s): Text (Holy Cross College text line) - 260-436-9598 Online - www.RedeemerRadio.com/Doctor E-mail - Doctor@RedeemerRadio.com Subscribe to the Podcast: iTunes | Google Play | SoundCloud | RSS

The show starts with a discussion about buying our first car. Brent tells a story about his co-worker getting a new car. The topic of the week is “Names”. Brent describes another story about how his co-worker names things. Wade goes into a discussion of how drugs are named. We transition to talking about how people are naming children and how people pick their own names. We finish the show with us talking about hyphenated names.

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

In this episode, we review historical and new treatment options for hepatitis C, including: peginterferon, rivabirin, boceprevir, telaprevir, sofosbuvir (Sovaldi), simeprevir (Olysio), ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak), and ledipasvir/sofosbuvir (Harvoni). May 18, 2015 - Correction added in the beginning of the episode regarding Viekira Pak dosing regimen.

Today in FirstWord:

Today in FirstWord: